Fortress Biotech
FBIO
#9186
Rank
A$0.16 B
Marketcap
A$5.30
Share price
5.72%
Change (1 day)
82.82%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -A$85.65 Million

According to Fortress Biotech 's latest financial reports the company's current earnings are A$62.3 Million. In 2024 the company made an earning of -A$0.19 Billion, an increase over its 2023 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$85.65 Million-52.95%
2024 -A$0.19 Billion-21.6%
2023 -A$0.24 Billion-28.03%
2022 -A$0.33 Billion29.88%
2021 -A$0.25 Billion59.8%
2020 -A$0.16 Billion1.17%
2019 -A$0.16 Billion-19.84%
2018 -A$0.2 Billion28.99%
2017 -A$0.15 Billion37.92%
2016 -A$0.11 Billion32.31%
2015 -A$81.43 Million164.31%
2014 -A$30.81 Million-45.14%
2013 -A$56.16 Million37.55%
2012 -A$40.83 Million-22.91%
2011 -A$52.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-A$51.42 Million-36.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
A$37.39 M-146.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 120.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-A$51.22 Million-36.62%๐Ÿ‡บ๐Ÿ‡ธ USA